What's The BUZZ?

Market News, Products, Services, and Trends

Advertisement

DoseMe: Advancing Precision Dosing with DoseMeRx

DoseMe: Advancing Precision Dosing with DoseMeRx

DoseMeRx by DoseMe delivers advanced precision dosing capabilities designed to optimize therapeutic drug monitoring and improve patient outcomes. Built for clinical efficiency and accuracy, the platform empowers healthcare professionals to individualize dosing decisions using real-time pharmacokinetic and pharmacodynamic (PK/PD) insights.

With real-time visualization of PK/PD data, clinicians can move beyond trial-and-error approaches and make informed dosing decisions faster. DoseMeRx enables accurate individualized dose calculations using minimal patient data, while also providing on-screen model fit assessments and integrated renal function tracking through a serum creatinine monitor—all within a single, streamlined interface.

The platform also supports flexible simulation of predicted outcomes, allowing users to evaluate dosing strategies across a range of therapeutic targets. By comparing results against established guidelines, clinicians can confidently optimize treatment decisions tailored to each patient’s needs.

Additionally, the Alternative Dosing Matrix simplifies regimen selection by presenting multiple dosing options based on individualized recommendations. Users can quickly explore variations in dose and interval, and with a single click, apply the preferred regimen for immediate calculation and evaluation.

By combining advanced analytics with intuitive design, DoseMeRx enhances clinical decision-making, reduces variability, and supports more precise, patient-centered care.

DoseMe

DoseMe News & Announcements

Today, DoseMeRx’s user-friendly software takes the pain out of manual dosing and simplifies AUC compliance, freeing up pharmacists to focus on what they do best. But as we’ve grown to become the largest Bayesian dosing platform in the US, we’ve never lost sight of what’s at the heart of our business (hint: it’s not software).

Emma Cidade

Posted by: Emma Cidade

Emma Cidade serves as a Pharmacy500 Market Analyst on the RXinsider Market Intelligence Division, where she creates Pharmacy500 INTEL Market Reports and client SPOTLIGHT videos. In addition, she develops educational content to help pharmacy professionals stay informed about industry trends, products, and services across the pharmacy supply chain. Cidade earned a Bachelor of Science in Marketing from the University of Rhode Island, with minors in Biology and Spanish. She combines her background in marketing, life sciences, and market research to develop educational resources that provide pharmacy professionals with valuable market insights and support informed decision-making.

SUBSCRIBE

Name
Subscription Choices
Checkboxes
Subscribe
Receive the latest news, product launches, and insights from RXinsider.

Request information from DoseMe: Advancing Precision Dosing with DoseMeRx

Name
Address
Subscribe